|
Test Catalog
|
|
Neurofibromatosis Type 2 DNA Test |
#635 |
|
| Type of Disorder: |
Neuromuscular Disorders |
|
| Typical Presentation: |
Bilateral vestibular schwannomas resulting in hearing loss |
|
| Disease(s) tested for: |
Vestibular schwannoma |
|
| Test Details |
|
| Test Code: |
635 |
|
| Informed Consent Required: |
Yes |
|
| Medicare ABN Required: |
Yes |
|
| Special Notes: |
Offered in partnership with Massachusetts General Hospital (MGH). Medicare patients must send samples directly to MGH. |
|
| Technical Information |
|
| Utility: |
Detects sequence variations in the NF2 gene |
|
| Methodology: |
Polymerase Chain Reaction (PCR), Single Strand Confirmation Polymorphism (SSCP) and DNA Sequencing |
|
| Reference Value: |
No mutation detected |
|
| CPT Code(s): |
83891(1), 83898(18), 83903(18), 83912(1) |
|
| Patents: |
N/A |
|
| Shipping Considerations |
|
| Preferred Specimen Requirements |
| Type: |
Whole blood |
| Minimum Volume: |
20ml |
| Collection Tube: |
Lavender top (EDTA) |
|
| Storage Conditions: |
Refrigerate |
|
| Shipping Conditions: |
Room temperature, ship within 24 hours of drawing |
|
| Test Turnaround: |
6 Months |
|
|
|
